In the world of drug development and medical innovation, clinical trials are the backbone of progress. However, the integrity of these trials is increasingly compromised by a rising and often overlooked issue: professional patients, also known as duplicate subjects in Clinical Trials. Who Are Professional Patients? Professional patients are individuals who enroll in multiple clinical …
GARDEN CITY, N.Y.–(BUSINESS WIRE)–Verified Clinical Trials (VCT), the world’s largest global research subject database designed to prevent dual enrollment in clinical trials with duplicate research subjects and protocol violations in clinical trials, proudly announces it has achieved ISO/IEC 27001 certification, the international gold standard for information security management systems (ISMS). This significant milestone reflects VCT’s ongoing dedication to …
Running a successful clinical trial requires precision, compliance, and above all—integrity of your data. One of the greatest threats to this integrity? Professional research subjects and duplicate subjects in clinical trials. Many sponsors and CROs underestimate the frequency and impact of dual enrollment in clinical trials. Yet, it’s not a matter of if it will …
Introduction In today’s fast-paced clinical research environment, ensuring data integrity and participant safety has never been more critical. One of the most persistent threats to these core objectives is the issue of duplicate research subjects in clinical trials—individuals who enroll in multiple studies concurrently or in close succession, often without disclosing prior participation. Verified Clinical …
Clinical trials for GLP-1 receptor agonists and obesity clinical trials face unique challenges due to the high level of interest from participants who are eager to lose weight or manage metabolic disorders. One major concern is duplicate enrollment in clinical trials, where subjects attempt to participate in multiple studies simultaneously. This can happen for several …
Clinical trials are the backbone of medical advancements, providing the data necessary to develop new treatments and therapies. However, one of the biggest challenges facing the research community is ensuring data integrity and participant safety. Duplicate subjects in clinical trials, fraudulent participation, and non-compliance can compromise results and endanger both subjects and the broader public. …
The integrity of clinical trials is paramount to ensuring reliable results, patient safety, and regulatory compliance. However, duplicate subjects in clinical trials—individuals who enroll in multiple studies simultaneously or in rapid succession—pose a significant risk to data accuracy and patient safety. The issue is not confined to specific regions such as Florida or California or …
The integrity of clinical trials hinges on ensuring that each participant is unique to the study and does not enroll multiple times in the same trial or across different studies. Duplicate research subjects introduce significant risks, compromising data validity, regulatory compliance, and overall study success. While detection efforts at the study’s conclusion can identify such …
NEW YORK, March 19, 2024 /PRNewswire/ — ProofPilot, the industry’s only platform for clinical trial automation, guidance and flawless execution, is excited to announce its strategic partnership with Verified Clinical Trials (VCT), the world’s leading validated research participant registry and verification platform. This collaboration marks a significant milestone in improving data integrity by reducing the risk of ineligible patients. VCT …
Nonadherence in clinical trials remains a significant hurdle, leading to compromised data integrity, skewed results, and costly delays. One often overlooked but critical factor contributing to nonadherence is the presence of duplicate subjects and professional research subjects—individuals who enroll in multiple trials simultaneously or misrepresent their participation history. The Hidden Impact of Duplicate Subjects Nonadherence …
